The findings described in this review indicate that the current understanding of STAT pathway has advanced to the point where different kind of therapeutic interventions are being developed to regulate aberrant activation of STAT protein in order to control chronic inflammation or improve prognosis of several cancers. The gene discussed is SOAT1; the disease is cancer.